EDdb: A web resource for eating disorder and its application to identify an extended adipocytokine signaling pathway related to eating disorder

Science China Life Sciences

Volumn 56, Issue 12, 2013, Pages 1086-1096

  Zhao, Min ^a   Li, XiaoMo ^a   Qu, Hong ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

adipocytokine signaling pathway; database; eating disorder; pathway analysis

Indexed keywords

ADIPOCYTOKINE;

ALGORITHM; ARTICLE; BODY WEIGHT; EATING DISORDER; FACTUAL DATABASE; FEMALE; GENETIC DATABASE; GENETICS; HUMAN; INTERNET; INTRAABDOMINAL FAT; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

ADIPOKINES; ALGORITHMS; BODY WEIGHT; DATABASES, FACTUAL; DATABASES, GENETIC; EATING DISORDERS; FEMALE; HUMANS; INTERNET; INTRA-ABDOMINAL FAT; METABOLIC SYNDROME X; PROTEIN INTERACTION MAPPING; SIGNAL TRANSDUCTION;

EID: 84889651246     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-013-4573-2     Document Type: Article

References (68)

1. Bulik C M, Hebebrand J, Keski-Rahkonen A, et al. Genetic epidemiology, endophenotypes, and eating disorder classification. Int J Eat Disord, 2007, 40: S52-60.
2. Swanson S A, Crow S J, Le Grange D, et al. Prevalence and correlates of eating disorders in adolescents: Results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry, 2011, 68: 714-723.
3. Wang K, Zhang H, Bloss C S, et al. A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. Mol Psychiatry, 2010, 16: 949-959.
4. Hudson J I, Hiripi E, Pope H G Jr., et al. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry, 2007, 61: 348-358.
5. Becker K G, Barnes K C, Bright T J, et al. The genetic association database. Nat Genet, 2004, 36: 431-432.
6. Chanoine P, Spector N D. Hyperlipidemia, eating disorders, and smoking cessation. Curr Opin Pediatr, 2008, 20: 734-739.
7. Anzengruber D, Klump K L, Thornton L, et al. Smoking in eating disorders. Eat Behav, 2006, 7: 291-299.
8. Morgan J F, Lacey J H. Smoking, eating disorders, and weight control. Postgrad Med J, 1999, 75: 127.
9. Dean E, Lomi C, Bruno S, et al. Addressing the common pathway underlying hypertension and diabetes in people who are obese by maximizing health: The ultimate knowledge translation gap. Int J Hypertens, 2011, 2011: 835805.
10. Schwartz M B, Henderson K E. Does obesity prevention cause eating disorders? J Am Acad Child Adolesc Psychiatry, 2009, 48: 784-786.
11. Waaddegaard M, Davidsen M, Kjoller M. Obesity and prevalence of risk behaviour for eating disorders among young Danish women. Scand J Public Health, 2009, 37: 736-743.
12. Day J, Ternouth A, Collier D A. Eating disorders and obesity: two sides of the same coin? Epidemiol Psichiatr Soc, 2009, 18: 96-100.
13. Nishisono F M. Understanding of and therapy for eating disorders-psychiatric views. Seishin Shinkeigaku Zasshi, 2009, 111: 854-858.
14. Lee S, Ng K L, Kwok K, et al. The changing profile of eating disorders at a tertiary psychiatric clinic in Hong Kong (1987-2007). Int J Eat Disord, 2010, 43: 307-314.
15. Javaras K N, Pope H G, Lalonde J K, et al. Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry, 2008, 69: 266-273.
16. Blinder B J. Eating disorders in psychiatric illness. West J Med, 1991, 155: 519-520.
17. Hinney A, Nguyen T T, Scherag A, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE, 2007, 2: e1361.
18. Scuteri A, Sanna S, Chen W M, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet, 2007, 3: e115.
19. Pinheiro A P, Bulik C M, Thornton L M, et al. Association study of 182 candidate genes in anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet, 2010, 153B: 1070-1080.
20. Scherag S, Hebebrand J, Hinney A. Eating disorders: The current status of molecular genetic research. Eur Child Adolesc Psychiatry, 2010, 19: 211-226.
21. Stark C, Breitkreutz B J, Chatr-Aryamontri A, et al. The BioGRID Interaction Database: 2011 update. Nucleic Acids Res, 2011, 39: D698-D704.
22. Prasad T S, Goel R, Kandasamy K, et al. Human Protein Reference Database-2009 update. Nucleic Acids Res, 2008, 37: D767-772.
23. Willis R C, Hogue C W. Searching, viewing, and visualizing data in the Biomolecular Interaction Network Database (BIND). Curr Protoc Bioinform, 2006, Chapter 8, Unit 8. 9.
24. Maglott D, Ostell J, Pruitt K D, et al. Entrez Gene: Gene-centered information at NCBI. Nucleic Acids Res, 2011, 39: D52-57.
25. Hermjakob H, Fleischmann W, Apweiler R. Swissknife - 'lazy parsing' of SWISS-PROT entries. Bioinformatics, 1999, 15: 771-772.
26. Croft D, O'Kelly G, Wu G, et al. Reactome: A database of reactions, pathways and biological processes. Nucleic Acids Res, 2011, 39: D691-697.
27. Feramisco J D, Sadreyev R I, Murray M L, et al. Phenotypic and genotypic analyses of genetic skin disease through the Online Mendelian Inheritance in Man (OMIM) database. J Invest Dermatol, 2009, 129: 2628-2636.
28. Kanehisa M, Goto S, Hattori M, et al. From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res, 2006, 34: D354-357.
29. Nishimura D. BioCarta. Biotech Softw Internet Rep, 2001, 2: 117-120.
30. Kong L, Cheng L, Fan L Y, et al. IQdb: An intelligence quotient score-associated gene resource for human intelligence. Database (Oxford), 2013, 2013: bat063.
31. Zhao M, Qu H. PathLocdb: A comprehensive database for the subcellular localization of metabolic pathways and its application to multiple localization analysis. BMC Genomics, 2010, 11: S13.
32. Zhao M, Chen X, Gao G, et al. RLEdb: A database of rate-limiting enzymes and their regulation in human, rat, mouse, yeast and E. coli. Cell Res, 2009, 19: 793-795.
33. Zhao M, Chen Y, Qu D, et al. TSdb: A database of transporter substrates linking metabolic pathways and transporter systems on a genome scale via their shared substrates. Sci China Life Sci, 2011, 54: 60-64.
34. Xie C, Mao X, Huang J, et al. KOBAS 2. 0: A web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res, 2011, 39: W316-322.
35. Huang da W, Sherman B T, Lempicki R A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res, 2009, 37: 1-13.
36. Bialecka M, Drozdzik M, Klodowska-Duda G, et al. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease. Acta Neurol Scand, 2004, 110: 260-266.
37. Urwin R E, Nunn K P. Epistatic interaction between the monoamine oxidase A and serotonin transporter genes in anorexia nervosa. Eur J Hum Genet, 2005, 13: 370-375.
38. Glaab E, Baudot A, Krasnogor N, et al. Extending pathways and processes using molecular interaction networks to analyse cancer genome data. BMC Bioinformatics, 2010, 11: 597.
39. Lorincz A M, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer, 2006, 13: 279-292.
40. Hoda M R, Hamza A, Fischer K, et al. Obesity as a risk factor for prostate cancer: Role for adipocytokines and involvement of tyrosine kinase pathway. Aktuelle Urol, 2010, 41: 178-183.
41. Nakajima T E, Yamada Y, Hamano T, et al. Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci, 2010, 101: 1286-1291.
42. Smith M R, Lee H, Fallon M A, et al. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. Urology, 2008, 71: 318-322.
43. Kaur T, Zhang Z F. Obesity, breast cancer and the role of adipocytokines. Asian Pac J Cancer Prev, 2005, 6: 547-552.
44. Housa D, Housova J, Vernerova Z, et al. Adipocytokines and cancer. Physiol Res, 2006, 55: 233-244.
45. Housova J, Anderlova K, Krizova J, et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab, 2005, 90: 1366-1370.
46. Tagami T, Satoh N, Usui T, et al. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab, 2004, 89: 1833-1837.
47. Morton G J, Cummings D E, Baskin D G, et al. Central nervous system control of food intake and body weight. Nature, 2006, 443: 289-295.
48. Belgardt B F, Okamura T, Bruning J C. Hormone and glucose signalling in POMC and AgRP neurons. J Physiol, 2009, 587: 5305-5314.
49. de Piano A, Tock L, Carnier J, et al. The role of nutritional profile in the orexigenic neuropeptide secretion in nonalcoholic fatty liver disease obese adolescents. Eur J Gastroenterol Hepatol, 2010, 22: 557-563.
50. Speliotes E K, Willer C J, Berndt S I, et al. Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat Genet, 2010, 42: 937-948.
51. Barth S, Klein P, Horbach T, et al. Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: Relation to endocrine and clinical parameters. Obes Facts, 2010, 3: 245-251.
52. Maury E, Brichard S M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol, 2010, 314: 1-16.
53. Galic S, Oakhill J S, Steinberg G R. Adipose tissue as an endocrine organ. Mol Cell Endocrinol, 2010, 316: 129-139.
54. Benton C R, Holloway G P, Han X X, et al. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats. Diabetologia, 2010, 53: 2008-2019.
55. Phillips C M, Goumidi L, Bertrais S, et al. ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat. J Lipid Res, 2010, 51: 3500-3507.
56. Steinberg G R, McAinch A J, Chen M B, et al. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab, 2006, 91: 3592-3597.
57. Karp P D, Ouzounis C A, Moore-Kochlacs C, et al. Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res, 2005, 33: 6083-6089.
58. Cellini E, Castellini G, Ricca V, et al. Glucocorticoid receptor gene polymorphisms in Italian patients with eating disorders and obesity. Psychiatr Genet, 2010, 20: 282-288.
59. Dostalova I, Kunesova M, Duskova J, et al. Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition, 2006, 22: 977-983.
60. Krizova J, Dolinkova M, Lacinova Z, et al. Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype. Physiol Res, 2008, 57: 539-546.
61. Zhao M, Qu H. High similarity of phylogenetic profiles of rate-limiting enzymes with inhibitory relation in human, mouse, rat, budding yeast and E. coli. BMC Genomics, 2011, 12: S10.
62. Zhao M, Qu H. Human liver rate-limiting enzymes influence metabolic flux via branch points and inhibitors. BMC Genomics, 2009, 10: S31.
63. Edwards Y J, Beecham G W, Scott W K, et al. Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach. PLoS ONE, 2011, 6: e16917.
64. Zhao M, Sun J, Zhao Z. Synergetic regulatory networks mediated by oncogene-driven microRNAs and transcription factors in serous ovarian cancer. Mol BioSyst, 2013, 9: 3187-3198.
65. Andrews R C, Walker B R. Glucocorticoids and insulin resistance: Old hormones, new targets. Clin Sci (Lond), 1999, 96: 513-523.
66. Rosmond R, Chagnon Y C, Holm G, et al. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res, 2000, 8: 211-218.
67. Meller N, Altman A, Isakov N. New perspectives on PKCtheta, a member of the novel subfamily of protein kinase C. Stem Cells, 1998, 16: 178-192.
68. Kim J K, Fillmore J J, Sunshine M J, et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest, 2004, 114: 823-827.